X4 PHARMACEUTICALS, INC Shares Outstanding (Cover Page)
X4 PHARMACEUTICALS, INC (XFOR) had Shares Outstanding (Cover Page) of 99.15 million shares as of 2026-07-31, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06
- 2026-07-31: Entity Common Stock, Shares Outstanding 99.15M shares.
- 2026-05-01: Entity Common Stock, Shares Outstanding 94.32M shares.
- 2026-03-12: Entity Common Stock, Shares Outstanding 90.92M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 87.44M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 99.15M shares 10-Q · filed 2026-08-06 |
| 2026-05-01 | 94.32M shares 10-Q · filed 2026-05-06 |
| 2026-03-12 | 90.92M shares 10-K · filed 2026-03-17 |
| 2025-10-31 | 87.44M shares 10-Q · filed 2025-11-05 |
| 2025-08-04 | 11.41M shares 10-Q · filed 2025-08-08 |
| 2025-04-28 | 5.79M shares 10-Q · filed 2025-05-01 |
| 2025-03-20 | 173.66M shares 10-K · filed 2025-03-26 |
| 2024-11-11 | 170.55M shares 10-Q · filed 2024-11-13 |
| 2024-08-05 | 168.50M shares 10-Q · filed 2024-08-08 |
| 2024-05-03 | 167.94M shares 10-Q · filed 2024-05-07 |
| 2024-03-18 | 167.94M shares 10-K · filed 2024-03-21 |
| 2023-11-07 | 167.29M shares 10-Q · filed 2023-11-09 |
| 2023-08-07 | 164.42M shares 10-Q · filed 2023-08-10 |
| 2023-05-01 | 122.21M shares 10-Q · filed 2023-05-04 |
| 2023-03-15 | 122.21M shares 10-K · filed 2023-03-21 |
| 2022-10-31 | 69.24M shares 10-Q · filed 2022-11-03 |
| 2022-08-01 | 68.65M shares 10-Q · filed 2022-08-04 |
| 2022-05-09 | 30.82M shares 10-Q · filed 2022-05-12 |
| 2022-03-14 | 30.81M shares 10-K · filed 2022-03-17 |
| 2021-10-29 | 24.71M shares 10-Q · filed 2021-11-04 |
| 2021-07-30 | 24.85M shares 10-Q · filed 2021-08-03 |
| 2021-05-03 | 23.66M shares 10-Q · filed 2021-05-06 |
| 2021-03-15 | 17.38M shares 10-K · filed 2021-03-19 |
| 2020-11-02 | 16.29M shares 10-Q · filed 2020-11-05 |
| 2020-07-30 | 16.18M shares 10-Q · filed 2020-08-04 |
| 2020-05-04 | 16.14M shares 10-Q · filed 2020-05-07 |
| 2020-03-06 | 16.13M shares 10-K · filed 2020-03-12 |
| 2019-11-04 | 12.46M shares 10-Q · filed 2019-11-07 |
| 2019-08-02 | 12.43M shares 10-Q · filed 2019-08-07 |
| 2019-05-05 | 12.42M shares 10-Q · filed 2019-05-15 |
| 2019-03-01 | 14.64M shares 10-K · filed 2019-03-11 |
| 2018-10-31 | 14.32M shares 10-Q · filed 2018-11-09 |
| 2018-07-31 | 14.32M shares 10-Q · filed 2018-08-13 |
| 2018-04-30 | 14.29M shares 10-Q · filed 2018-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |